Repare Therapeutics Inc. (NASDAQ: RPTX) announced it will present initial data from its Phase 1 LIONS clinical trial at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE